Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
US Pharmaceuticals Ishares ETF
(NY:
IHE
)
71.72
+0.44 (+0.62%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about US Pharmaceuticals Ishares ETF
A Look At Pharma ETFs Post Q1 Earnings
May 07, 2024
Pharma ETFs have delivered mixed performances over the past month.
Via
Talk Markets
Topics
ETFs
ETFs To Buy As Eli Lilly Beats Q1 Earnings, Lifts Outlook
May 01, 2024
Eli Lilly and Company posted mixed first-quarter 2024 earnings, beating earnings estimates but lagging on revenues. Investors seeking to tap the opportune moment could bet on ETFs having the largest...
Via
Talk Markets
Topics
ETFs
April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market
April 30, 2024
Performance in April 2024: Utilities lead, real estate lags. S&P 500, Nasdaq 100, Dow Jones Industrial Average, small-cap and large-cap indices all decline.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
3 Sector ETFs That Beat The Market Last Week
August 14, 2023
Here are three ETFs from different sectors that were in green last week.
Via
Talk Markets
Topics
ETFs
US Pharmaceuticals: A Bifurcated Market
January 12, 2022
The US pharmaceutical industry faces two important goals that conflict with each other.
Via
Talk Markets
Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors
February 26, 2024
Zealand Pharma's drug showed positive results in 83% of patients in Phase 2 trials for MASH, heating up the race for new obesity drugs and pushing the company's shares 30% higher.
Via
Benzinga
A Look At Pharma ETFs After Q4 Earnings
February 12, 2024
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth.
Via
Talk Markets
Topics
ETFs
Bank Of America Predicts 10 2024 Market Surprises: From Booming IPOs To Japanese Equity Surge
January 09, 2024
Bank of America lists 10 market surprises; warns investors to be wary of the bond market's dovish position compared to the Fed.
Via
Benzinga
Topics
Bonds
Exposures
Debt Markets
3 Beaten-Down ETFs To Buy For A Turnaround In 2024
December 22, 2023
Following three consecutive monthly losses since the COVID pandemic began in March 2020, Wall Street recorded a robust recovery starting in November. we have highlighted ETFs from different zones that...
Via
Talk Markets
Topics
ETFs
Exposures
COVID-19
5 Secret Santa ETFs That Might Surprise You This Christmas
December 16, 2023
Wall Street has been sizzling hot this holiday season. This is likely to continue, given that the Santa Claus rally is on the way. Against such a backdrop, there are some hidden gems which could...
Via
Talk Markets
Topics
ETFs
Pharmacy Workers Strike At CVS and Walgreens, Echoing Wider Pharma Sector Unrest
November 05, 2023
In a recent surge of labor unrest, pharmacy employees from CVS Health Corporation (NYSE: CVS) and Walgreens Boots Alliance, Inc. (NASDAQ: WBA) raised their voices by calling out sick or walking out...
Via
Benzinga
5 Sector ETFs That Outperformed in Turbulent August
August 30, 2023
Wall Street has lost momentum since the start of August, triggered by the series of bank downgrades and fears of higher rates for a longer-than-expected period.
Via
Talk Markets
Topics
ETFs
Q2 Earnings & Market Sell-Off Impact: 5 Must-See ETF Charts
August 25, 2023
While longer-than-expected rate worries and banking concerns led to feeble trading in recent weeks, a few equity ETFs rose or saw a modest decline over the past month.
Via
Talk Markets
Topics
ETFs
Pharma ETFs in Focus Post Q2 Earnings
August 11, 2023
Second-quarter earnings for the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 30.7% on 5% revenue growth.
Via
Talk Markets
Topics
ETFs
3 Biotech Stocks to Sell in June Before They Crash and Burn
June 06, 2023
Investors should get out of these biotech stocks to sell now that the Covid-19 pandemic is largely over. These's worse in store for them.
Via
InvestorPlace
Pharma ETFs Gain Post Q1 Earnings
May 09, 2023
Pharma ETFs have been in the green over the past month.
Via
Talk Markets
A Look At Pharma ETFs Post Q4 Earnings
February 08, 2023
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. However, solid earnings failed to fully impress pharma ETFs over the past month.
Via
Talk Markets
4 Sector ETFs To Watch Ahead Of Mid-Election Results
November 10, 2022
Some market analysts are signaling that a political gridlock by Republicans may be a positive for Wall Street and the U.S. economy.
Via
Talk Markets
5 ETFs To Watch After 2022 Midterm Elections: Which Sectors Win From Republican Or Democrat Majority?
November 09, 2022
The 2022 election was held on Tuesday, Nov. 8. No decision has been made as to who won many of the key battles, including several pivotal seats in the U.S. House of Representatives and U.S. Senate.
Via
Benzinga
Pharma ETFs In Focus Post Q3 Earnings
November 09, 2022
Many industry bigwigs reported solid results with some beating on earnings or revenues or both. However, solid earnings failed to fully impress pharma ETFs over the past month.
Via
Talk Markets
ETF Mid-Year Outlook & Investing Strategies
July 22, 2022
While positioning the portfolio for the second half investors should focus on three themes: 1) embracing volatility, 2) living with inflation, and 3) the long-term impacts of shortages.
Via
Talk Markets
Wave of Solid Q3 Earnings Push Pharma ETFs Higher
November 09, 2021
The slew of Q3 results has led to smooth trading in pharma ETFs over the past month.
Via
Talk Markets
J&J ETFs to Gain on Upbeat COVID-19 Vaccine Data
September 25, 2021
Johnson & Johnson has again announced positive data highlighting the efficiency of its single-shot COVID-19 vaccine in providing protection against COVID-related hospitalizations.
Via
Talk Markets
Exposures
COVID-19
Will Pfizer ETFs Soar on FDA's COVID-19 Vaccine Booster Approval?
September 24, 2021
Investors have one more reason to cheer the COVID-19 vaccine update as the FDA has approved emergency use of a booster dose of the Pfizer Inc. and BioNTech SE COVID-19 vaccine.
Via
Talk Markets
Exposures
COVID-19
Product Safety
3 Dividend-Paying Pharmaceutical Stocks to Buy This Summer
June 05, 2021
The pharmaceutical industry has benefited from much investor attention amid the COVID-19 pandemic.
Via
Talk Markets
Exposures
COVID-19
Tuesday Talk: Slip Sliding Sideways
May 18, 2021
With the Middle East seemingly going to Hell in a proverbial handbasket the markets seem to be slip sliding, not away (as the Paul Simon song would have it) sideways as it were.
Via
Talk Markets
5 Sector ETFs That Survived Last Week's Turmoil
May 17, 2021
Here are five sector ETFs that performed well last week and survived the broad market rout.
Via
Talk Markets
Pharma ETFs in Focus Post Q1 Earnings
May 12, 2021
The slew of Q1 results has led to mixed trading in pharma ETFs over the past month. Here are those in detail.
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.